| Title : Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes - Serra_2008_Int.J.Clin.Pharmacol.Ther_46_349 |
| Author(s) : Serra D , He YL , Bullock J , Riviere GJ , Balez S , Schwartz S , Wang Y , Ligueros-Saylan M , Jarugula V , Dole WP |
| Ref : Int J Clinical Pharmacology & Therapeutics , 46 :349 , 2008 |
| Abstract : Serra_2008_Int.J.Clin.Pharmacol.Ther_46_349 |
| ESTHER : Serra_2008_Int.J.Clin.Pharmacol.Ther_46_349 |
| PubMedSearch : Serra_2008_Int.J.Clin.Pharmacol.Ther_46_349 |
| PubMedID: 18793589 |
Serra D, He YL, Bullock J, Riviere GJ, Balez S, Schwartz S, Wang Y, Ligueros-Saylan M, Jarugula V, Dole WP (2008)
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes
Int J Clinical Pharmacology & Therapeutics
46 :349
Serra D, He YL, Bullock J, Riviere GJ, Balez S, Schwartz S, Wang Y, Ligueros-Saylan M, Jarugula V, Dole WP (2008)
Int J Clinical Pharmacology & Therapeutics
46 :349